Ori Gutwerg - 05 Mar 2025 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
SVP, GENERICS
Signature
/s/ Ori Gutwerg, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
05 Mar 2025
Net transactions value
-$323,049
Form type
4
Filing time
07 Mar 2025, 16:09:27 UTC
Previous filing
04 Mar 2025
Next filing
14 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Options Exercise $9,447 +300 +0.3% $31.49 99,476 05 Mar 2025 Direct
transaction ANIP Common Stock Sale $18,009 -300 -0.3% $60.03 99,176 05 Mar 2025 Direct
transaction ANIP Common Stock Sale $305,040 -5,084 -5.1% $60.00 94,092 05 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIP Stock Option (right to buy) Options Exercise $9,447 -300 -2.2% $31.49 13,204 05 Mar 2025 Common Stock 300 $31.49 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold in multiple trades at prices ranging from $60.00 to $60.03. The price reported above reflects the weighted average sales price.
F2 25% of the total options vested on each of February 15, 2022, February 15, 2023, February 15, 2024, and February 15, 2025.